Arsenic trioxide suppresses paclitaxel‐induced mitotic arrest
Open Access
- 28 April 2009
- journal article
- Published by Wiley in Cell Proliferation
- Vol. 42 (3) , 404-411
Abstract
Objectives: To understand if there exists a functional interaction between arsenic trioxide and paclitaxel in vitro.Materials and methods: HeLa and HCT116 (ρ53+/+ and ρ53−/−) cells were treated with As2O3 and/or paclitaxel for various times. Treated cells were collected for analyses using a combination of flow cytometry, fluorescence microscopy and Western blotting.Results: Because As2O3 is capable of inhibiting tubulin polymerization and inducing mitotic arrest, we examined whether there existed any functional interaction between As2O3 and paclitaxel, a well‐known microtubule poison. Flow cytometry and fluorescence microscopy revealed that although As2O3 alone caused a moderate level of mitotic arrest, it greatly attenuated paclitaxel‐induced mitotic arrest in cells with p53 deficiency. Western blot analysis showed that As2O3 significantly blocked phosphorylation of BubR1, Cdc20, and Cdc27 in cells treated with paclitaxel, suggesting that arsenic compromised the activation of the spindle checkpoint. Our further studies revealed that the attenuation of paclitaxel‐induced mitotic arrest by As2O3 resulted primarily from sluggish cell cycle progression at S phase but not enhanced mitotic exit.Conclusion: The observations that As2O3 has a negative impact on the cell cycle checkpoint activation by taxol should have significant clinical implications because the efficacy of taxol in the clinics is associated with its ability to induce mitotic arrest and subsequent mitotic catastrophe.Keywords
This publication has 37 references indexed in Scilit:
- Insights into the carcinogenic mode of action of arsenicToxicology and Applied Pharmacology, 2007
- p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1The Journal of Pharmacology and Experimental Therapeutics, 2006
- Cell death by mitotic catastrophe: a molecular definitionOncogene, 2004
- Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cellsLeukemia, 2003
- Arsenic trioxide, a therapeutic agent for APLOncogene, 2001
- Arsenic Trioxide Induces G2/M Growth Arrest and Apoptosis after Caspase-3 Activation and Bcl-2 Phosphorylation in Promonocytic U937 CellsBiochemical and Biophysical Research Communications, 2001
- Distribution of γ-tubulin in multipolar spindles and multinucleated cells induced by dimethylarsinic acid, a methylated derivative of inorganic arsenics, in Chinese hamster V79 cellsToxicology, 1999
- Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition PoreExperimental Cell Research, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Induction of p53 protein expression by sodium arseniteMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997